Stocksigma LogoStocksigma Logo

Clinitech Laboratory Reports H1'27 Results and Full IPO Proceeds Utilization

Clinitech Laboratory reported consolidated revenue from operations of ₹942.41 lakhs for the half-year ended 30th Sep'26, rising 85.5% YoY compared to

Clinitech Laboratory Reports H1'27 Results and Full IPO Proceeds Utilization

Clinitech Laboratory Ltd · Outcome · 13 Nov 2026, 6:55 pm

Clinitech Laboratory Reports H1'27 Results and Full IPO Proceeds Utilization Clinitech Laboratory reported consolidated revenue from operations of ₹942.41 lakhs for the half-year ended 30th Sep'26, rising 85.5% YoY compared to ₹508.02 lakhs in H1'26. Consolidated profit after tax attributable to owners grew 27.6% YoY to ₹38.33 lakhs from ₹30.03 lakhs, with basic EPS increasing to ₹1.59 from ₹1.32. On a standalone basis, revenue reached ₹549.32 lakhs, while PAT stood at ₹24.46 lakhs. Additionally, the company fully utilized its net IPO proceeds of ₹578.30 lakhs, deploying ₹498.67 lakhs toward diagnostic business expansion.

Original exchange filing (PDF)

More announcements from Clinitech Laboratory Ltd

All Clinitech Laboratory Ltd announcements